Metraipolis › archive › dc_83bf1587f2f0

Eculizumab in C3 Glomerulopathy: A Systematic Review of Therapeutic Efficacy and Clinical Outcomes — Europe PMC PMID:41155921

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41155921
DOI: 10.3390/pharmaceutics17101284
License (as archived): solo-consultazione
Archived: 2026-11-09T15:30:02.682Z
SHA-256 of the archived text: b02409dc201618058eb0e7c2ce4a8dccdd6485f0b158be1392e540430d97fca3
Stable URL of this page: https://metraipolis.com/documento/dc_83bf1587f2f0

How to cite

Eculizumab in C3 Glomerulopathy: A Systematic Review of Therapeutic Efficacy and Clinical Outcomes — Europe PMC PMID:41155921 — Europe PMC (en), https://europepmc.org/article/MED/41155921 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_83bf1587f2f0 (Metraipolis archive dc_83bf1587f2f0, sha256 b02409dc201618058eb0e7c2ce4a8dccdd6485f0b158be1392e540430d97fca3)

BibTeX

@misc{dc83bf1587f2f0,
  title = {Eculizumab in C3 Glomerulopathy: A Systematic Review of Therapeutic Efficacy and Clinical Outcomes — Europe PMC PMID:41155921},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155921},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_83bf1587f2f0; sha256 b02409dc201618058eb0e7c2ce4a8dccdd6485f0b158be1392e540430d97fca3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155921. Agents can read the archived copy with the MCP tool read_document.